None
Conditions
Interventions
Experimental group (securement device group):Patients assigned to fixation devices use traditional indwelling needle fixation patches and new airbag compression fixation materials
Control group:Patients assigned to the control group were fixed with a patch using a conventional short peripheral venous catheter
Sponsors
The First Hospital of Shanxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Including but not limited to patients with dermatological diseases such as drug rash, chronic eczema, psoriasis, contact dermatitis, etc., or skin barrier dysfunction due to prolonged hospitalization, post-surgery, etc., manifested by dermatological changes such as skin dryness, oozing, eczema, dermatitis, etc.; 2. The retention site is the forearm, the back of the hand, and long-term intravenous infusion treatment is required (>=4 days); 3. The age of the patient is 18 years old or older; and 4. Those who signed the informed consent form and voluntarily participated in this study.
Exclusion criteria
Exclusion criteria: 1. patients with a history of allergy to nonwoven or balloon materials; 2. patients with infection, ulceration, necrosis, or severe edema at the puncture site; and 3. patients who are unable to cooperate with the study interventions (e.g., patients with impaired consciousness or psychiatric disorders).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fixation effect (Rate of indwelling needle patch displacement/dislodgement);Fixation effect (Duration of indwelling needle fixation);Fixed effect (changing times of indwelling needle film);Cost analysis;Comfort; | — |
Countries
China
Contacts
Public ContactLi Li
The First Hospital of Shanxi Medical University
Outcome results
None listed